SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Attack II - A Complete Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Haim R. Branisteanu who wrote (43229)2/13/2003 3:47:11 PM
From: Paul Shread  Respond to of 52237
 
14:34 ET Johnson & Johnson likely to get Cypher approval within a month (JNJ) 50.82 +1.03: We are hearing from traders citing Bloomberg that Medicare chief Thomas Scully told a congressional panel that JNJ's Cypher drug-coated stent is likely to win FDA approval within the next month. (Co said yesterday it saw a March/April timeframe for approval.)